Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. Programs
  3. Clinician's Roundtable

Using Testosterone for Refractory Prostate Cancer

ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Presenters
Comments
  • Overview

    Host Dr. Bruce Bloom welcomes Dr. Walter Stadler, professor of medicine and director of the genitourinary program at the University of Chicago Pritzker School of Medicine. We are still working toward a highly effective treatment for hormone refractory prostate cancer. Could a paradoxical treatment with high-dose testosterone hold the key to a cure? Dr. Stadler details current clinical research on this somewhat controversial topic.

Recommended
Details
Presenters
Comments
  • Overview

    Host Dr. Bruce Bloom welcomes Dr. Walter Stadler, professor of medicine and director of the genitourinary program at the University of Chicago Pritzker School of Medicine. We are still working toward a highly effective treatment for hormone refractory prostate cancer. Could a paradoxical treatment with high-dose testosterone hold the key to a cure? Dr. Stadler details current clinical research on this somewhat controversial topic.

Schedule6 Oct 2024